VRC-EBODNA023-00-VP

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVRC-EBODNA023-00-VP
Drug Alias NameEbola DNA vaccineDNA/rAd5 prime-boost Ebola vaccinenucleic acid vaccineVRC-EBODNA023-00-VP
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUganda
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsMarburg Virus Disease

Other Information

ATC CodeN/A
Related LinksN/A